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Abstract
The Mal/SRF transcription factor is regulated by the level of G-actin in cells and has important roles in cell migration
and other actin-dependent processes in Drosophila. A recent report suggests that Mal/SRF and an upstream
regulator, Pico, are required for cell proliferation and tissue growth in Drosophila. I find otherwise. Mutation of Mal
or SRF does not affect cell proliferation in the fly wing. Furthermore, I cannot reproduce the reported effects of Pico
RNAi or Pico overexpression on body size. Nevertheless, I can confirm that overexpression of Pico or Mal causes
tissue overgrowth specifically in the fly wing - where SRF is most highly expressed. My results indicate that Mal/SRF
can promote tissue growth when abnormally active, but is not normally required for tissue growth during
development.
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Introduction
The control of tissue growth in Drosophila requires the action of
multiple signalling pathways that often have conserved roles in
mammalian development and cancer [1,2,3]. It was recently
reported that tissue growth in Drosophila also depends on a
signalling pathway involving the lammelipodin homologue Pico
and the Mal/SRF transcription factor [4]. This pathway has been
well studied in mammalian cells, where it has been shown that
high levels of G-actin in cells activate Mal and promote its
translocation to the nucleus where it binds to and activates the
SRF transcription factor [5]. Mal/SRF has important functions in
cell migration and other actin-dependent processes in both
Drosophila and mammals [6,7], as well as regulating cell fate in
the Drosophila wing [8], but only a single report by Lyulcheva et al
claims that this transcription factor regulates tissue growth in
Drosophila [4].
The evidence that Lyulcheva et al present that Pico, Mal and
SRF regulate tissue growth in Drosophila is largely based on
overexpression of Pico and Mal - which were reported to increase
wing size [4]. In addition, overexpression of Pico was also reported
to increase the size of the whole body, suggesting that this pathway
might control growth in all tissues [4]. Finally, RNAi knockdown
of Pico was found to reduce wing size and body size [4]. Lyulcheva
et al concluded that Pico is required for tissue and organismal
growth and that Pico acts via control of mitogenic SRF signalling
[4].
Since no loss of function analysis of the requirement for Mal
or SRF in cell proliferation or tissue growth has been
performed, I decided to carry this out. Surprisingly, my results
conflict with those reported by Lyulcheva et al and suggest
that signalling through Mal/SRF is not required for cell
proliferation or tissue growth during fly development. I also
find that ectopic activation of Mal can stimulate tissue
growth, but only in the fly wing, where SRF is most highly
expressed.
Results
To test the requirement for the mal and blistered (bs,e n c o d i n g
SRF) genes in cell proliferation, I generated clones of cells
marked by the absence of GFP in the developing fly wing with
the hs.flp/FRT method. I find that wild-type clones, mal
S9 null
mutant clones, and bs
14 null mutant clones all proliferate
normally, reaching similar sizes as their twin-spot (bright GFP)
clones (Fig. 1A–C). I then used en.flp/FRT Minute or hh.flp/FRT
Minute methods to generate adult wings containing large clones
that fill the entire posterior compartment. Wings with wild-type
or mal
S9 mutant posterior compartments were normally sized
( F i g .1 D , E ) .W i n g sw i t habs
14 mutant posterior compartment
exhibited a transformation of all cell types to vein fate - due to a
well established requirement for SRF in vein patterning that is
independent of Mal (Fig. 1F) [8]. Since vein cells are smaller
than inter-vein cells, due to apical constriction, the size of the
wing is reduced due to this morphological change (Fig. 1G,H).
Wild-type eyes and malS9 mutant eyes generated with the ey.flp/
FRT Minute method were normally sized (Fig. 1I,J). These
results show that Mal/SRF activity is not required for cell
p r o l i f e r a t i o ni nt h ef l yw i n go re y e .
I next overexpressed Mal in both the wing and the eye to
examine its effect on tissue growth. I find that, as reported by
Lyulcheva et al, overexpressed Mal causes overgrowth of the fly
wing when driven in either the posterior compartment (Fig. 2A,B)
or in the whole wing (Fig. 2C,D). In contrast, overexpression of
Mal in the fly eye thoughout development does not cause tissue
overgrowth (Fig. 2E,F). These results show that ectopically
expressed Mal can induce tissue growth, but specifically in the
fly wing.
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model that Pico regulates tissue and organismal growth via
regulation of Mal/SRF. I therefore repeated the published
experiments expressing UAS.pico or UAS.pico-IR (an RNAi-
inducing inverted repeat) transgenes obtained from the
authors in the whole fly. I find that neither transgene affects
body size or average weight (act.G4 control = 0.0025g; act.G4
UAS.pico = 0.0024 g; act.G4 UAS.pico-IR = 0.0027 g)
compared with control animals (Fig. 3A–F). Expression of
the same transgenes thoughout eye development also had no
effect on eye size (Fig. 3G,H). These results suggest that Pico is
not a general regulator of tissue or organismal growth in
Drosophila.
My experiments with Pico overexpression and RNAi knock-
down in the whole body revealed some effects on wing
development. I therefore specifically expressed UAS.pico or
UAS.pico-IR in the fly wing with a strong wing Gal4 driver. I
find that overexpression of Pico causes tissue overgrowth
(Fig. 4A,B), similar to overexpression of Mal (Fig. 2C,D),
confirming previous work. However, RNAi knockdown of Pico
does not cause a clean tissue undergrowth phenotype but instead
causes crumpling of the wing, suggesting that a defect in
morphogenesis, rather than growth, may be responsible
for reduced wing size. These results suggest that Pico is required
for wing morphogenesis and that, like Mal, overexpression of Pico
can induce tissue overgrowth specifically in the wing.
Discussion
My results conflict with a previous report by Lyulcheva et al
suggesting that Pico is an essential regulator of tissue and
organismal growth that acts by regulating Mal/SRF [4]. I instead
find that Mal and SRF are dispensable for cell proliferation and
tissue growth in Drosophila. SRF does affect the final size of the
wing, but via regulation of cell fate rather than cell proliferation.
Any requirement for Pico in cell proliferation is therefore not
mediated by Mal/SRF but is rather an indirect effect of Pico, most
likely via its role in maintaining actin-dependent cellular
morphology. Consistent with this, analysis of pico mutant clones
indicates that the mutant cells are extruded from the epithelium
[4].
Although Mal/SRF is dispensable for tissue growth, my results
confirm that ectopic activation of this transcription factor is
capable of causing tissue overgrowth in the wing. Overexpression
of Pico or Mal is sufficient to induce Mal/SRF driven overgrowth
of the wing, but has little effect elsewhere in the adult body. This is
Figure 1. Mal/SRF is not required for cell proliferation in the fly wing or eye. (A) Clones of control cells (absence of GFP) and their twin
s p o t s( b r i g h tG F P )a r er o u g h l yt h es a m es i z e ,i n d i c a ting normal rates of proliferation. (B) Clones of mal
S9 mutant cells (absence of GFP) and
their twin spots (bright GFP) are roughly the same size, indicating normal rates of proliferation. (C) Clones of bs
14 mutant cells (absence of
GFP) and their twin spots (bright GFP) are roughly the same size, indicating normal rates of proliferation. (D) A control wing containing wild-
type cells in the posterior compartment. Genotype is indicated. (E) A wing containing mal
S9 mutant cells in the posterior compartment.
Genotype is indicated. (F) A wing containing bs
14 mutant cells in the posterior compartment. Genotype is indicated. (G) A pupal wing
expressing E-cad GFP. (H) A close up of a wing vein from (G). (I) A wild-type fly eye. (J) A malS9 mutant fly eye, genotype indicated, is normally
sized.
doi:10.1371/journal.pone.0010077.g001
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expressed in all fly tissues but appears to be expressed in a specific
pattern in the developing wing [8]. Thus, in imaginal epithelia
where SRF is expressed, ectopic activation of Mal can drive tissue
overgrowth.
The SRF expression pattern corresponds to the future
intervein wing cells, with SRF absent in developing veins [8].
Loss of SRF (in bs mutants) causes intervein cells to transform into
vein cells [8]. Loss of Mal does not affect vein patterning,
consistent with the view that SRF promotes intervein fate
independently of Mal.
In conclusion, the normal function of SRF is to pattern the fly
wing, however, in the presence of ectopically active Mal, SRF can
also promote tissue overgrowth. Mal/SRF might therefore have a
role in promoting tumour growth in humans and it will be
interesting to determine whether Mal is ectopically active tumours
and whether it is sufficient to drive tissue growth in mouse models.
Materials and Methods
Drosophila genetics
FRT malS9 and FRT bs14 were obtained from P. Rorth [6].
en.Gal4 UAS.Flp and hh.Gal4 UAS.Flp were obtained from J-P.
Vincent [9]. UAS.mal, UAS.pico, and UAS.picoIR stocks were
obtained from D. Bennett [4]. Other stocks were obtained from
the Bloomington Drosophila stock centre.
Fly crosses were performed at 25uC and adult flies were
dissected and examined by bright field microscopy. Wings were
fixed in ethanol, dipped in distilled water and then mounted on
glass slides in Hoyer’s medium. Imaginal discs and pupal wings
were examined with a Leica SP5 laser-scanning confocal
microscope.
Figure 3. Pico is not required to regulate body size or eye
size. (A) A control act.Gal4 fly. (B) A control arm.Gal4 fly. (C)
Ubiquitous overexpression of Pico with act.Gal4 does not change
body size, but does affect wing morphology. (D) Ubiquitous
overexpression of Pico with arm.Gal4 does not change body size,
but does affect wing morphology. (E) Ubiquitous RNAi knockdown
of Pico with act.Gal4 does not change body size, but does affect
wing morphology. (F) Ubiquitous RNAi knockdown of Pico with
arm.Gal4 does not change body size, but does affect wing
morphology. (G) RNAi knockdown of Pico in the eye with ey.flp
act.STOP.Gal4 produces normally sized eyes. (H) Overexpression
of Pico in the eye with ey.flp act.STOP.Gal4 produces normally
sized eyes.
doi:10.1371/journal.pone.0010077.g003
Figure 2. Overexpression of Mal causes overgrowth in the
wing, but not the eye. (A) A control en.Gal4 wing. (B)
Overexpression of Mal in the posterior compartment with en.Gal4
causes overgrowth. (C) A control ms1096.Gal4 wing. (D) Overex-
pression of Mal in the whole wing with ms1096.Gal4 causes
overgrowth. (E) A control ey.Gal4 GMR.Gal4 eye. (F) Overexpre-
ssion of Mal in the eye with ey.Gal4 GMR.Gal4 does not affect eye
size.
doi:10.1371/journal.pone.0010077.g002
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Clone sizes were quantified based on the number of cells/
nuclei per clone (observed by DAPI staining) and average
cell number per clone and standard deviations were
graphed using Microsoft Excel for both clones and twin
spots.
Wing sizes were quantified with ImageJ (the pixel measurement
function) for multiple wings from both control and test animals.
Average wing size and standard deviations were calculated with
Microsoft Excel and expressed as a percentage of wild-type size
(=100%).
Body weight was measured by collecting a defined number of
female flies in an eppendorf tube and measuring their weight with
a fine balance relative to an empty eppendorf tube. Average fly
weight was determined by dividing the total weight by the number
of flies.
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Figure 4. Pico is required for morphogenesis in the wing and can
drive overgrowth when overexpressed. (A) A control ms1096.Gal4
wing. (B) Overexpression of Pico with ms1096.Gal4 drives overgrowth,
similar to overexpression of Mal. (C,D) RNAi knockdown of Pico with
ms1096.Gal4 causes blisters (C) or crumpling (D) but does not strongly
reduce wing size.
doi:10.1371/journal.pone.0010077.g004
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